Mindpeak GmbH is a Hamburg-based startup specializing in building automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Their mission is to make AI-based pathological analysis accessible globally, assisting cancer experts to provide reliable and reproducible diagnoses.

The company's AI tools help reduce tedious and repetitive tasks such as cell and biomarker quantification, allowing specialists to focus on more complex cases. The AI delivers explainable results, fostering pathologists' trust.

Mindpeak develops AI-powered diagnostic software integrated into histology-based in-vitro diagnostics (IVDs) including companion diagnostics. Their products cover a broad range of applications, including detection and quantification of PD-L1, HER2, Ki-67, ER/PR, and detection of breast metastases and nail fungus. The AI solutions are CE-marked and designed for clinical diagnostics, translational research, and clinical trial services.

The company emphasizes deep integration of their AI algorithms into partner software, enhancing pathologists' workflows, as well as providing a standalone AI console for image analysis. Mindpeak collaborates with various partners worldwide, including clinics, research institutions, and AI companies.

Mindpeak GmbH is located at Zirkusweg 2, 20359 Hamburg, Germany.

Founded in 2018, the managing director is Felix Faber.

They can be contacted via email at [email protected] or telephone at +49 40 35 67 67 97.

LinkedIn: https://www.linkedin.com/company/mindpeak-gmbh/

Careers and job opportunities can be found at: https://www.mindpeak.ai/careers